☆ 4.4 Article

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Volume 71, Issue 6, Pages 206-211

Publisher

Centers for Disease Control MMWR Office

DOI: 10.15585/mmwr.mm7106a4

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Publisher

Centers for Disease Control MMWR Office

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Publisher

Centers for Disease Control MMWR Office

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper